| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | 0.0076 | 0.9 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.0071 | 0.9 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | -0.0062 | 0.9 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |